NNNN · Anbio Biotechnology
Market Cap
$316.89M
Shares
43.89M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-13 | 263 | $9.89 | $2,601 |
| 2026-08-10 | 1,110 | $10.61 | $11,777 |
| 2026-08-07 | 1,187 | $9.75 | $11,573 |
| 2026-08-06 | 92 | $10.15 | $934 |
| 2026-08-05 | 4,145 | $10.15 | $42,072 |
| 2026-08-04 | 50 | $10.65 | $533 |
| 2026-08-03 | 175 | $9.90 | $1,733 |
| 2026-07-30 | 327 | $11.59 | $3,790 |
| 2026-07-29 | 163 | $10.15 | $1,654 |
| 2026-07-28 | 61 | $10.18 | $621 |
| 2026-07-27 | 816 | $9.90 | $8,078 |
| 2026-07-23 | 1,432 | $9.45 | $13,532 |
| 2026-07-22 | 1,300 | $9.52 | $12,376 |
| 2026-07-21 | 153 | $9.52 | $1,457 |
| 2026-07-17 | 5 | $9.60 | $48 |
| 2026-07-15 | 2,203 | $9.51 | $20,951 |
| 2026-07-10 | 1,877 | $11.15 | $20,929 |
| 2026-07-09 | 1,687 | $11.49 | $19,384 |
| 2026-07-08 | 1,737 | $11.70 | $20,323 |
| 2026-07-07 | 588 | $12.04 | $7,080 |
| 2026-07-06 | 13 | $12.70 | $165 |
| 2026-07-01 | 367 | $13.71 | $5,032 |
| 2026-06-30 | 1,138 | $13.55 | $15,420 |
| 2026-06-29 | 2,194 | $14.53 | $31,879 |
| 2026-06-26 | 316 | $16.10 | $5,088 |
| 2026-06-25 | 1,538 | $15.25 | $23,455 |
| 2026-06-23 | 22 | $16.47 | $362 |
| 2026-06-22 | 87 | $16.64 | $1,448 |
| 2026-06-18 | 61 | $15.86 | $967 |
| 2026-06-17 | 74 | $16.14 | $1,194 |
| 2026-06-16 | 26 | $16.81 | $437 |
| 2026-06-15 | 3,305 | $15.59 | $51,525 |
| 2026-06-12 | 2,097 | $16.44 | $34,475 |
| 2026-06-11 | 1,724 | $16.43 | $28,325 |
| 2026-06-10 | 4,463 | $16.16 | $72,122 |
| 2026-06-09 | 2,137 | $17.22 | $36,799 |
| 2026-06-08 | 22 | $22.99 | $506 |
| 2026-06-05 | 1,780 | $27.01 | $48,078 |
| 2026-06-04 | 3,689 | $28.51 | $105,173 |
| 2026-06-03 | 407 | $32.12 | $13,073 |
Showing 1–40 of 40 settlements
Key facts
CIK
1982708
CUSIP
G0367B105
13F (30d)
10 filings
10 filers
Visit website
Investor relations